Results 1 to 10 of about 1,622 (69)

Reversión del bloqueo neuromuscular inducido por vecuronio: sugammadex o neostigmina

open access: yesRevista Cubana de Anestesiología y Reanimación, 2014
Introducción: se han descrito diferencias entre la reversión de los bloqueantes neuromusculares con sugammadex y neostigmina. La mayoría concuerda que los resultados con sugammadex son superiores.
Migdel G. Abreu Darias   +2 more
doaj   +4 more sources

[Post-traumatic stress and quality of life of post-COVID-19 patients in primary care]. [PDF]

open access: yesAten Primaria, 2022
Becerra-Canales B   +3 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Therapeutic approaches for Duchenne muscular dystrophy

Nature Reviews Drug Discovery, 2023
Thomas C Roberts, Kay E Davies
exaly  

Duchenne muscular dystrophy

Nature Reviews Disease Primers, 2021
Dongsheng Duan   +2 more
exaly  

Spinal muscular atrophy

Nature Reviews Disease Primers, 2022
Francesco Muntoni, Richard S Finkel
exaly  

Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial

Nature Medicine, 2022
Kevin A Strauss   +2 more
exaly  

Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial

Nature Medicine, 2022
Kevin A Strauss   +2 more
exaly  

Base editing rescue of spinal muscular atrophy in cells and in mice

Science, 2023
Mandana Arbab   +2 more
exaly  

Pharmacological strategies for muscular dystrophy

Nature Reviews Drug Discovery, 2003
Tejvir S Khurana, Kay E Davies
exaly  

Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study

Lancet, The, 2018
Craig M Mcdonald   +2 more
exaly  
reversión del bloqueo
sugammadex
neostigmina
1  2  3  4  5  

Home - About - Disclaimer - Privacy